HbA1c, a key biomarker used to measure long-term blood glucose control, is gaining renewed attention as diabetes prevalence rises and treatment strategies evolve. Unlike daily glucose readings, HbA1c offers a three-month snapshot of blood sugar trends, making it central to diagnosis, therapy assessment, and risk management. Recent clinical focus highlights its role not only in monitoring diabetes but also in predicting complications and guiding personalized care.